{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:50:08Z","timestamp":1794981008385,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis is a life-threatening condition driven by a maladaptive host response to infection. To establish a standardized blood transcriptomic subtype model, we aggregated blood transcriptomics data from two major sepsis cohorts: the Molecular Diagnosis and Risk Stratification of Sepsis (MARS) project (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009678 sampled on intensive care unit admission; ClinicalTrials.gov registration no.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT01905033\" ext-link-type=\"uri\">NCT01905033<\/jats:ext-link>\n                    ) and the Genomic Advances in Sepsis (GAinS) study (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009444 sampled on intensive care unit admission and\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009817 follow-up samples; ClinicalTrials.gov registration no.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT00131196\" ext-link-type=\"uri\">NCT00131196<\/jats:ext-link>\n                    ). We demonstrate a strong interconnection across three separate classification methods, resulting in the proposed groupings of three consensus transcriptomic subtypes (CTSs). The distinguishing characteristics of CTS1 included gene activation of typical inflammatory pathways, more pronounced endothelial activation and an overall immature neutrophil theme. CTS2 was characterized by gene activation of a heme metabolism pathway, fibrinolytic disturbances and platelet and eosinophil signatures. CTS3 was associated with genes involved in the activation of allograft rejection, interferon signaling and anticoagulation functions, together with lymphocyte and nonclassical monocyte features. Evaluating CTS classification in independent patient cohorts, specifically the vasopressin vs noradrenaline as initial therapy in septic shock (VANISH) randomized controlled trial (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009176; ISRCTN registration no.\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN20769191\" ext-link-type=\"uri\">ISRCTN20769191<\/jats:ext-link>\n                    ) and patients hospitalized with suspected sepsis at a district hospital in Uganda (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009128), ascertained the robustness of our approach. Notably, post hoc analysis of a pseudo-randomized cohort, along with a reanalysis of the VANISH trial data, unmasked a harmful signal in CTS2-assigned patients treated with corticosteroids. The CTS classification method aligns diverse sepsis transcriptomic subgroupings into a robust, reproducible framework, thereby enabling biological interpretation and potentially assisting aspects of clinical trial design to advance precision medicine in sepsis.\n                  <\/jats:p>","DOI":"10.1038\/s41591-025-03964-5","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:04:18Z","timestamp":1759223058000},"page":"4119-4130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["A consensus blood transcriptomic framework for sepsis"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-0341","authenticated-orcid":false,"given":"Brendon P.","family":"Scicluna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiki","family":"Cano-Gamez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-2933","authenticated-orcid":false,"given":"Katie L.","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-2576","authenticated-orcid":false,"given":"Andrew Reese","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6012-2232","authenticated-orcid":false,"given":"Soumen","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-8324","authenticated-orcid":false,"given":"Charles J.","family":"Hinds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-1108","authenticated-orcid":false,"given":"Olaf L.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-4708","authenticated-orcid":false,"given":"Purvesh","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3596-1093","authenticated-orcid":false,"given":"Timothy E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-5536","authenticated-orcid":false,"given":"Julian C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-5079","authenticated-orcid":false,"given":"Tom","family":"van der Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"3964_CR1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395, 200\u2013211 (2020).","journal-title":"Lancet"},{"key":"3964_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet 392, 75\u201387 (2018).","journal-title":"Lancet"},{"key":"3964_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","volume":"319","author":"HC Prescott","year":"2018","unstructured":"Prescott, H. C. & Angus, D. C. Enhancing recovery from sepsis: a review. JAMA 319, 62\u201375 (2018).","journal-title":"JAMA"},{"key":"3964_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall, J. C. Why have clinical trials in sepsis failed? Trends Mol. Med. 20, 195\u2013203 (2014).","journal-title":"Trends Mol. Med."},{"key":"3964_CR5","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.15252\/emmm.201810128","volume":"12","author":"J-M Cavaillon","year":"2020","unstructured":"Cavaillon, J.-M., Singer, M. & Skirecki, T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol. Med. 12, e10128 (2020).","journal-title":"EMBO Mol. Med."},{"key":"3964_CR6","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll, T., Shankar-Hari, M. & Wiersinga, W. J. The immunology of sepsis. Immunity 54, 2450\u20132464 (2021).","journal-title":"Immunity"},{"key":"3964_CR7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407\u2013420 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"3964_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport, E. E. et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir. Med. 4, 259\u2013271 (2016).","journal-title":"Lancet Respir. Med."},{"key":"3964_CR9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna, B. P. et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir. Med. 5, 816\u2013826 (2017).","journal-title":"Lancet Respir. Med."},{"key":"3964_CR10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/rccm.201608-1685OC","volume":"196","author":"KL Burnham","year":"2017","unstructured":"Burnham, K. L. et al. Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia. Am. J. Respir. Crit. Care Med. 196, 328\u2013339 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3964_CR11","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney, T. E. et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit. Care Med. 46, 915\u2013925 (2018).","journal-title":"Crit. Care Med."},{"key":"3964_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","volume":"16","author":"NL Stanski","year":"2020","unstructured":"Stanski, N. L. & Wong, H. R. Prognostic and predictive enrichment in sepsis. Nat. Rev. Nephrol. 16, 20\u201331 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"3964_CR13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe, D. B. et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am. J. Respir. Crit. Care Med. 199, 980\u2013986 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3964_CR14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","volume":"384","author":"AC Gordon","year":"2021","unstructured":"Gordon, A. C. et al. Interleukin-6 receptor antagonists in critically Ill patients with Covid-19. N. Engl. J. Med. 384, 1491\u20131502 (2021).","journal-title":"N. Engl. J. Med."},{"key":"3964_CR15","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","volume":"27","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou, E. et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat. Med. 27, 1752\u20131760 (2021).","journal-title":"Nat. Med."},{"key":"3964_CR16","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"O Abani","year":"2021","unstructured":"Abani, O. et al. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637\u20131645 (2021).","journal-title":"Lancet"},{"key":"3964_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccm.2016.01.003","volume":"37","author":"TE Sweeney","year":"2016","unstructured":"Sweeney, T. E. & Wong, H. R. Risk stratification and prognosis in sepsis: What have we learned from microarrays? Clin. Chest Med. 37, 209\u2013218 (2016).","journal-title":"Clin. Chest Med."},{"key":"3964_CR18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander, S. et al. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir. Med. 12, 305\u2013322 (2024).","journal-title":"Lancet Respir. Med."},{"key":"3964_CR19","doi-asserted-by":"crossref","first-page":"eabq4433","DOI":"10.1126\/scitranslmed.abq4433","volume":"14","author":"E Cano-Gamez","year":"2022","unstructured":"Cano-Gamez, E. et al. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression. Sci. Transl. Med. 14, eabq4433 (2022).","journal-title":"Sci. Transl. Med."},{"key":"3964_CR20","doi-asserted-by":"crossref","first-page":"e58597","DOI":"10.7554\/eLife.58597","volume":"9","author":"BP Scicluna","year":"2020","unstructured":"Scicluna, B. P. et al. The leukocyte non-coding RNA landscape in critically ill patients with sepsis. eLife 9, e58597 (2020).","journal-title":"eLife"},{"key":"3964_CR21","doi-asserted-by":"crossref","first-page":"100587","DOI":"10.1016\/j.xgen.2024.100587","volume":"4","author":"KL Burnham","year":"2024","unstructured":"Burnham, K. L. et al. eQTLs identify regulatory networks and drivers of variation in the individual response to sepsis. Cell Genom. 4, 100587 (2024).","journal-title":"Cell Genom."},{"key":"3964_CR22","doi-asserted-by":"publisher","unstructured":"Van Dongen, S. Graph clustering via a discrete uncoupling process. SIAM J. Matrix Anal. Appl. 30, https:\/\/doi.org\/10.1137\/040608635 (2008).","DOI":"10.1137\/040608635"},{"key":"3964_CR23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw, P. J. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53\u201365 (1987).","journal-title":"J. Comput. Appl. Math."},{"key":"3964_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Series B"},{"key":"3964_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-022-03907-3","volume":"26","author":"MJ Cummings","year":"2022","unstructured":"Cummings, M. J. et al. Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in Uganda. Crit. Care 26, 36 (2022).","journal-title":"Crit. Care"},{"key":"3964_CR26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon, A. C. et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316, 509\u2013518 (2016).","journal-title":"JAMA"},{"key":"3964_CR27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","volume":"24","author":"AJ Kwok","year":"2023","unstructured":"Kwok, A. J. et al. Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat. Immunol. 24, 767\u2013779 (2023).","journal-title":"Nat. Immunol."},{"key":"3964_CR28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"3964_CR29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/CCM.0000000000004842","volume":"49","author":"KM DeMerle","year":"2021","unstructured":"DeMerle, K. M. et al. Sepsis subclasses: a framework for development and interpretation. Crit. Care Med. 49, 748\u2013759 (2021).","journal-title":"Crit. Care Med."},{"key":"3964_CR30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S2213-2600(23)00468-X","volume":"12","author":"M Shankar-Hari","year":"2024","unstructured":"Shankar-Hari, M. et al. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies. Lancet Respir. Med. 12, 323\u2013336 (2024).","journal-title":"Lancet Respir. Med."},{"key":"3964_CR31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","volume":"49","author":"RBE van Amstel","year":"2023","unstructured":"van Amstel, R. B. E. et al. Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes. Intensive Care Med. 49, 1360\u20131369 (2023).","journal-title":"Intensive Care Med."},{"key":"3964_CR32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri.2018.26","volume":"18","author":"JG Burel","year":"2018","unstructured":"Burel, J. G. & Peters, B. Discovering transcriptional signatures of disease for diagnosis versus mechanism. Nat. Rev. Immunol. 18, 289\u2013290 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"3964_CR33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"S-C Cheng","year":"2016","unstructured":"Cheng, S.-C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406\u2013413 (2016).","journal-title":"Nat. Immunol."},{"key":"3964_CR34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1164\/rccm.201707-1339LE","volume":"197","author":"BP Scicluna","year":"2018","unstructured":"Scicluna, B. P. et al. Molecular biomarker to assist in diagnosing abdominal sepsis upon ICU admission. Am. J. Respir. Crit. Care Med. 197, 1070\u20131073 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3964_CR35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1164\/rccm.201502-0355OC","volume":"192","author":"BP Scicluna","year":"2015","unstructured":"Scicluna, B. P. et al. A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. Am. J. Respir. Crit. Care Med. 192, 826\u2013835 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"3964_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14975-w","volume":"11","author":"MB Mayhew","year":"2020","unstructured":"Mayhew, M. B. et al. A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections. Nat. Commun. 11, 1177 (2020).","journal-title":"Nat. Commun."},{"key":"3964_CR37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.40793","volume":"71","author":"MP Ashton","year":"2019","unstructured":"Ashton, M. P. et al. Association of dendritic cell signatures with autoimmune inflammation revealed by single\u2010cell profiling. Arthritis Rheumatol. 71, 817\u2013828 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"3964_CR38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"EF McKinney","year":"2010","unstructured":"McKinney, E. F. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 16, 586\u2013591 (2010).","journal-title":"Nat. Med."},{"key":"3964_CR39","doi-asserted-by":"crossref","first-page":"106360","DOI":"10.1016\/j.jinf.2024.106360","volume":"89","author":"BE Dedeoglu","year":"2024","unstructured":"Dedeoglu, B. E., Tanner, A. R., Brendish, N. J., Moyses, H. E. & Clark, T. W. Comparison of two rapid host-response tests for distinguishing bacterial and viral infection in adults with acute respiratory infection. J. Infect. 89, 106360 (2024).","journal-title":"J. Infect."},{"key":"3964_CR40","volume":"12","author":"MD Iglesias-Ussel","year":"2025","unstructured":"Iglesias-Ussel, M. D. et al. A rapid host response blood test for bacterial\/viral infection discrimination using a portable molecular diagnostic platform. Open Forum Infect. Dis. 12, ofae729 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"3964_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fimmu.2016.00155","volume":"7","author":"F S\u00f4nego","year":"2016","unstructured":"S\u00f4nego, F. et al. Paradoxical roles of the neutrophil in sepsis: protective and deleterious. Front. Immunol. 7, 155 (2016).","journal-title":"Front. Immunol."},{"key":"3964_CR42","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1182\/blood-2014-07-587709","volume":"125","author":"K Martinod","year":"2015","unstructured":"Martinod, K. et al. PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood 125, 1948\u20131956 (2015).","journal-title":"Blood"},{"key":"3964_CR43","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2013-04-457671","volume":"122","author":"BG Yipp","year":"2013","unstructured":"Yipp, B. G. & Kubes, P. NETosis: how vital is it? Blood 122, 2784\u20132794 (2013).","journal-title":"Blood"},{"key":"3964_CR44","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1160\/TH14-02-0126","volume":"112","author":"SF de Stoppelaar","year":"2014","unstructured":"de Stoppelaar, S. F., van \u2018t Veer, C. & van der Poll, T. The role of platelets in sepsis. Thromb. Haemost. 112, 666\u2013677 (2014).","journal-title":"Thromb. Haemost."},{"key":"3964_CR45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12630-021-01920-8","volume":"68","author":"Z Al Duhailib","year":"2021","unstructured":"Al Duhailib, Z., Farooqi, M., Piticaru, J., Alhazzani, W. & Nair, P. The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping review. Can. J. Anaesth. 68, 715\u2013726 (2021).","journal-title":"Can. J. Anaesth."},{"key":"3964_CR46","volume":"9","author":"S Ong","year":"2018","unstructured":"Ong, S. et al. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence. Cell Death Dis. 9, 266 (2018).","journal-title":"Cell Death Dis."},{"key":"3964_CR47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fimmu.2020.00066","volume":"11","author":"G Canesin","year":"2020","unstructured":"Canesin, G., Hejazi, S. M., Swanson, K. D. & Wegiel, B. Heme-derived metabolic signals dictate immune responses. Front. Immunol. 11, 66 (2020).","journal-title":"Front. Immunol."},{"key":"3964_CR48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4266\/acc.2024.00647","volume":"39","author":"FC Fredrick","year":"2024","unstructured":"Fredrick, F. C., Meda, A. K. R., Singh, B. & Jain, R. Critical illness-related corticosteroid insufficiency: latest pathophysiology and management guidelines. Acute Crit. Care 39, 331\u2013340 (2024).","journal-title":"Acute Crit. Care"},{"key":"3964_CR49","volume":"12","author":"J Niu","year":"2021","unstructured":"Niu, J. et al. Identification of key immune-related genes in the progression of septic shock. Front. Genet. 12, 668527 (2021).","journal-title":"Front. Genet."},{"key":"3964_CR50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00001721-199306000-00002","volume":"4","author":"KD Bottles","year":"1993","unstructured":"Bottles, K. D. & Morrissey, J. H. Dexamethasone enhances agonist induction of tissue factor in monocytes but not in endothelial cells. Blood Coagul. Fibrinolysis 4, 405\u2013414 (1993).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"3964_CR51","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.178.3.1845","volume":"178","author":"MD de Kruif","year":"2007","unstructured":"de Kruif, M. D. et al. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J. Immunol. 178, 1845\u20131851 (2007).","journal-title":"J. Immunol."},{"key":"3964_CR52","doi-asserted-by":"publisher","unstructured":"Moore, A. R. et al. International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.12.623298 (2024).","DOI":"10.1101\/2024.11.12.623298"},{"key":"3964_CR53","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"3964_CR54","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"3964_CR55","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1093\/bioinformatics\/btq431","volume":"26","author":"BS Carvalho","year":"2010","unstructured":"Carvalho, B. S. & Irizarry, R. A. A framework for oligonucleotide microarray preprocessing. Bioinformatics 26, 2363\u20132367 (2010).","journal-title":"Bioinformatics"},{"key":"3964_CR56","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"3964_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"3964_CR58","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/JLB.4A0219-050R","volume":"106","author":"HN Khan","year":"2019","unstructured":"Khan, H. N. et al. Leukocyte transcriptional signatures dependent on LPS dosage in human endotoxemia. J. Leukoc. Biol. 106, 1153\u20131160 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"3964_CR59","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck, S., Spellman, P. T., Birney, E. & Huber, W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat. Protoc. 4, 1184\u20131191 (2009).","journal-title":"Nat. Protoc."},{"key":"3964_CR60","doi-asserted-by":"crossref","first-page":"i473","DOI":"10.1093\/bioinformatics\/bts370","volume":"28","author":"Y Shih","year":"2012","unstructured":"Shih, Y. & Parthasarathy, S. Identifying functional modules in interaction networks through overlapping Markov clustering. Bioinformatics 28, i473\u2013i479 (2012).","journal-title":"Bioinformatics"},{"key":"3964_CR61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2105-9-439","volume":"9","author":"M Slawski","year":"2008","unstructured":"Slawski, M., Daumer, M. & Boulesteix, A. CMA: a comprehensive Bioconductor package for supervised classification with high dimensional data. BMC Bioinformatics 9, 439 (2008).","journal-title":"BMC Bioinformatics"},{"key":"3964_CR62","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"3964_CR63","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3964_CR64","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J. C. & Vincent, J.-L. Biomarkers of sepsis: time for a reappraisal. Crit. Care 24, 287 (2020).","journal-title":"Crit. Care"},{"key":"3964_CR65","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00134-024-07586-2","volume":"50","author":"M Girardis","year":"2024","unstructured":"Girardis, M. et al. Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis. Intensive Care Med. 50, 1580\u20131592 (2024).","journal-title":"Intensive Care Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03964-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03964-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:06Z","timestamp":1765814406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03964-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":65,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3964"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03964-5","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.K. is co-founder, consultant to and a scientific adviser to Inflammatix. T.E.S. is co-founder, employee of and shareholder in Inflammatix. O.L.C. received in kind and in cash contributions to research from ImmuneXpress (2015\u20132019), Abionic (2021\u20132022), Prolira (2022\u20132024) and Presymptom Health (2023\u20132026). E.E.D. and K.L.B. report that the Wellcome Sanger Institute is supported by core funding from the Wellcome Trust (206194, 220540\/Z\/20\/A). J.C.K. and K.C.-G. report funding from a grant to their institution from the Danaher Beacon Programme for work on RNA biomarker point-of-care test development for SRS in sepsis. T.v.d.P. reports research grants from the EU\u2019s Horizon 2020 programme (FAIR, Immunosep), Inflammatix and the Ministry of Economic Affairs & Health Holland (all paid to the institution). For the purpose of open access, the authors have applied a CC BY public copyright license to any author-accepted manuscript version arising from this submission. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}